Retirement
◄ back to all posts

ORGS: Orgenesis, Inc. Stock

Written by | Jul, 6, 2018

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 89.60
Enterprise Value ($M) 72.80
Book Value ($M) 28.35
Book Value / Share 1.82
Price / Book 3.02
NCAV ($M) 7.65
NCAV / Share 0.49
Price / NCAV 22.58

Profitability (mra)
Return on Invested Capital (ROIC) -0.88
Return on Assets (ROA) -0.37
Return on Equity (ROE) -1.17

Liquidity (mrq)
Quick Ratio 1.67
Current Ratio 1.77

Balance Sheet (mrq) ($M)
Current Assets 30.30
Assets 75.45
Liabilities 22.64
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 18.66
Operating Income -14.65
Net Income -19.10
Earnings Per Share Basic -1.28
Earnings Per Share Diluted -1.31

Cash Flow Statement (mra) ($M)
Cash From Operations -15.68
Cash from Investing -6.27
Cash from Financing -6.27

Source:
Fintel.io

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2019-01-08 13D/A Bultot Hugues 4.20 -11.98
2018-03-22 13D/A Universite Libre De Bruxelles 4.03 -60.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

Source:
Fintel.io

Date Insider Trades Code Shares Value

Source:
Fintel.io

File Date Form SEC Filings
2019-02-13 10-K ORGS / Orgenesis, Inc. FORM 10-K (Annual Report)
2018-10-12 10-Q ORGS / Orgenesis, Inc. FORM 10-Q (Quarterly Report)
2018-07-17 10-Q ORGS / Orgenesis, Inc. FORM 10-Q (Quarterly Report)
2018-04-16 10-Q ORGS / Orgenesis, Inc. FORM 10-Q (Quarterly Report)

Source:
Fintel.io

Similar Companies
OPHT – Ophthotech Corp OPK – Opko Health, Inc.
OREX – Orexigen Therapeutics, Inc. ORMP – Oramed Pharmaceuticals, Inc.
OSIR – Osiris Therapeutics, Inc.


Financial data and stock pages provided for FREE by
Fintel.io




2018/07/06
◄ back to all posts